Dr. Lin on Combination Atezolizumab and Chemoradiation in Locally Advanced NSCLC
June 10th 2019Cancer Network spoke with Steven H. Lin, MD, PhD, of MD Anderson Cancer Center, on the findings of a phase II trial of atezolizumab plus chemoradiation therapy in locally advanced non-small-cell lung cancer.
Real-World Data Shed Light on Checkpoint Inhibitors for NSCLC Patients With Autoimmune Disease
June 5th 2019A retrospective study finds that use of checkpoint inhibitors is associated with similar survival outcomes among patients with advanced non–small-cell lung cancer, regardless of a history of autoimmune disorders.